AI Science Tracker
EN

OMRS pathology features associate with oral-leukoplakia progression

University of Texas Southwestern Medical Center; University of Texas MD Anderson Cancer Center · 31 Jan 2023 · medicine

Discovery

OMRS pathology features associate with oral-leukoplakia progression

Source check: Source checked. Not independent scientific confirmation.

Finding: A modified Inception-v3 model learned normal and malignant oral-epithelium features, then scored leukoplakia slides from 62 patients without concurrent cancer. The high-score group had a reported adjusted hazard ratio of 4.52 for progression to oral cancer. This was a small retrospective prognostic analysis; the classifier used a separate 38-biopsy development set, and broader clinical utility and treatment benefit remain untested.

Technology: OMRS; Inception-v3

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Modified Inception-v3 classifies oral histology patches, quantifies tumor-like epithelium in leukoplakia and links scores to subsequent clinical progression.
Test and result
Slide-separated development and 62-patient retrospective progression analysis; adjusted hazard ratio 4.52.
Limitation / still unknown
Small training/cohort sizes, external transportability and intervention benefits remain unresolved.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10067069/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary full paper relevant model Methods, study Results and limitations; exact primary front-matter identity and Europe PMC metadata checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.